**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
|----------------|--------------------------------------|----------|-----------|
|----------------|--------------------------------------|----------|-----------|
| 5949-29-1 |Citric acid monohydrate | >97 | unlisted |
+----------------+--------------------------------------+----------+-----------+
Text for R-phrases: see Section 16
Hazard Symbols: XI
Risk Phrases: 36/37/38
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Irritating to eyes, respiratory system and skin.
Potential Health Effects
Eye:
Causes severe eye irritation and possible injury.
Skin:
Causes skin irritation.
Ingestion:
May cause gastrointestinal irritation with nausea, vomiting and
diarrhea. Excessive intake of citric acid may cause erosion of the
teeth.
Inhalation:
Causes respiratory tract irritation.
Chronic:
Repeated exposure may cause erosion of teeth. Chronic exposure may
cause effects similar to those of acute exposure.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
In case of contact, immediately flush eyes with plenty of water for
at least 15 minutes. Get medical aid immediately.
Skin:
In case of contact, flush skin with plenty of water. Remove
contaminated clothing and shoes. Get medical aid if irritation
develops and persists. Wash clothing before reuse.
Ingestion:
If swallowed, do not induce vomiting unless directed to do so by
medical personnel. Never give anything by mouth to an unconscious
person. Get medical aid.
Inhalation:
If inhaled, remove to fresh air. If not breathing, give artificial
respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. During a fire, irritating and highly toxic gases
may be generated by thermal decomposition or combustion. This
material in sufficient quantity and reduced particle size is capable
of creating a dust explosion.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal
container. Clean up spills immediately, observing precautions in the
Protective Equipment section. Avoid generating dusty conditions.
Provide ventilation. Spill may be carefully neutralized with lime
(calcium oxide, CaO).
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Remove contaminated clothing and
wash before reuse. Use with adequate ventilation. Minimize dust
generation and accumulation. Keep container tightly closed. Avoid
ingestion and inhalation. Do not get in eyes. Avoid contact with skin
and clothing.
Storage:
Store in a tightly closed container. Store in a cool, dry,
well-ventilated area away from incompatible substances. Store
protected from moisture.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate
ventilation to keep airborne concentrations low.
Exposure Limits
CAS# 77-92-9:
CAS# 5949-29-1:
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
Follow the OSHA respirator regulations found in 29
CFR 1910.134 or European Standard EN 149. Use a
NIOSH/MSHA or European Standard EN 149 approved
respirator if exposure limits are exceeded or if
irritation or other symptoms are experienced.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Crystalline powder
Color: white
Odor: Odorless.
pH: 2.2 (0.1N soln)
Vapor Pressure: 3.70E-009 mm Hg @ 25 deg C
Viscosity: Not available.
Boiling Point: 175 deg C (dec)
Freezing/Melting Point: 100 deg C
Autoignition Temperature: 1010 deg C ( 1,850.00 deg F)
Flash Point: Not applicable.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature: 175 deg C
Solubility in water: Freely Soluble.
Specific Gravity/Density: 1.542 g/cm3
Molecular Formula: C6H8O7.H2O
Molecular Weight: 210.15
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Dust generation, moisture.
Incompatibilities with Other Materials:
Metals, strong oxidizing agents, strong reducing agents, strong
bases, metal nitrates.
Hazardous Decomposition Products:
Carbon monoxide, irritating and toxic fumes and gases, carbon
dioxide.
Hazardous Polymerization: Will not occur.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 77-92-9: GE7350000
CAS# 5949-29-1: GE7810000
LD50/LC50:
CAS# 77-92-9: Draize test, rabbit, eye: 750 ug/24H Severe; Draize
test, rabbit, skin: 500 mg/24H Mild; Oral, mouse: LD50 = 5040 mg/kg;
Oral, rat: LD50 = 3 gm/kg.
CAS# 5949-29-1.
Carcinogenicity:
Citric acid anhydrous -
Not listed by ACGIH, IARC, or NTP.
Citric acid monohydrate -
Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XI
Risk Phrases:
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 37/39 Wear suitable gloves and eye/face
protection.
WGK (Water Danger/Protection)
CAS# 77-92-9: 0
CAS# 5949-29-1: 0
Canada
CAS# 77-92-9 is listed on Canada's DSL List.
CAS# 77-92-9 is listed on Canada's Ingredient Disclosure List.
CAS# 5949-29-1 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 77-92-9 is listed on the TSCA inventory.
CAS# 5949-29-1 is not on the TSCA Inventory because it is a hydrate.
It is considered to be listed if the CAS number for the anhydrous form
is on the inventory (40CFR720.3(u)(2)).
**** SECTION 16 - ADDITIONAL INFORMATION ****
Text for R-phrases from Section 2
MSDS Creation Date: 2/09/1999 Revision #7 Date: 2/25/2004
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
L-1-4'-Tosylamino-2-Phenylethyl Chloromethyl Ketone, 99+%
| 402-71-1 |
|
4-Methylumbelliferone phosphate, 99.5% (hplc)
| 3368-04-5 |
|
6-Chloro-meta-anisidine hydrochloride, 98%
| 2401-24-3 |
|
5-Indanol, 99%
| 1470-94-6 |
|
1,1-Dichloroethane,99+%, Stabilized with Nitromethane
| 75-34-3 |
|
2,3-Dihydro-2-Oxo-1H-Imidazol-4-Carbox-Aldehyde, 99%
| 0-00-1 |
|
2,5-Dihydroxy-1,4-Benzenedisulfonic Acid, Dipotassium Salt, 98%
| 15763-57-2 |
|
Phenacyltriphenylphosphonium bromide 96%
| 6048-29-9 |
|
cis-Pinonic acid, 98%
| 473-72-3 |
|
Camphene, 75%, Remainder Mainly Alpha-Fenchene
| 79-92-5 |
|
Scopolamine Hydrobromide Trihydrate, 99.0-101.0% (On The Anhydrous
| 6533-68-2 |
|
n-Methoxymethylaza-18-crown-6, 96%
| |
|
Benzyl Propionate, 98+%
| 122-63-4 |
|
1-Methyl-1-Phenylhydrazine, 98% (titr.)
| 618-40-6 |
|
O-(4-Nitrobenzyl)hydroxylamine hydrochloride, 98%
| 2086-26-2 |
|
alpha-Benzoin oxime, 98%
| 441-38-3 |
|
Oxalyl monoguanylhydrazide, 97% (titr.)
| 89797-67-1 |
|
3-Chlorobenzoic Acid, 98% (Titr.)
| 535-80-8 |
|
(R)-(+)-alpha-(1-Naphthyl)ethylamine 99+%
| 3886-70-2 |
|
Cyanocobalamin
| 68-19-9 |
|
Isopropan(ol-d), 98+ atom % d
| 3979-51-9 |
|
2-Bromostyrene, 98%, Stabilized With 0.005% 4-Tert.-Butylcatechol
| 2039-88-5 |
|
Methylamine-d5 deuteriochloride, 98+ atom % D
| 593-51-1 |
|
3,5-Dimethylphenol, 99+%
| 108-68-9 |
|
2-Chloro-5-nitrobenzonitrile, 99%
| 16588-02-6 |
|
6-Bromoveratraldehyde, 97%
| 5392-10-9 |
|
3,5-Dichlorobenzonitrile, 97%
| 6575-00-4 |
|
Methyl (R)-(-)-3-Hydroxybutyrate, 99%
| 3976-69-0 |
|
4-CHLOROSTYRENE, 98% (GC)
| 1073-67-2 |
|
Ethyl 2-hydroxyethyl sulfide, 98%
| 110-77-0 |
|
2-Bromobutane, 99+% (GC)
| 78-76-2 |
|
4-Bromo-2,2-Diphenylbutyronitrile, 95+%
| 39186-58-8 |
|
Acridine-4, 9-Dicarboxylic Acid Monohydrate
| 27574-29-4 |
|
N-Aminomorpholine, 97%(GC)
| 4319-49-7 |
|
Cyclohexyl Diphenyl Phosphine
| 6372-42-5 |
|
2,4-Diamino-6-Mercaptopyrimidine Hemisulfate, Tech.
| 81012-96-6 |
|
Diethyl Succinate, 99%
| 123-25-1 |
|
1,3-Difluoro-4-iodobenzene, 99+%
| 2265-93-2 |
|
Mono-methyl 5-nitroisophthalate, 98%
| 1955-46-0 |
|
Citric acid monohydrate
| 77-92-9 |
|
3-Pyrrolidino-1,2-Propanediol, 96%
| 85391-19-1 |
|
Delta-Valerolactam, 99%
| 675-20-7 |
|
Cycloheptyl Bromide, 97%
| 2404-35-5 |
|
Penicillin G Potassium Salt
| 113-98-4 |
|
Nicotinic acid hydrazide, 97%
| 553-53-7 |
|
Ethyl (2r,3r)-2,3-epoxy-3-methylpropanoate 96%
| 19780-35-9 |
|
Beta-Sitosterol, ca 75% Beta-Sitosterol, With ca 10% Campesterol
| |
|
3-Hydroxy-4(2-Hydroxy-4-Sulfo-1-Naphtyl Azo)naphthalene-2-Carboxylic
| 3737-95-9 |
|
Streptomycin sulfate
| 3810-74-0 |
|
Cyanogen Bromide
| 506-68-3 |
|
|